Tus kws kho mob
QP35-19 Billing Code Change for Minnesota Health Care Programs Subscribers for Rule 25 and Comprehensive Assessments
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 10, 2019
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 3061 - 3070 ntawm 3600
Tus kws kho mob
2019 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P32-19 eviCore Radiology Program Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P34-19 Change to Prior Authorization Requirements for Outpatient Therapies and Chiropractic Services for Commercial and Medicare Products
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P26R1-19 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P36-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Utilization Management Program
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2019
Tus kws kho mob
QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy
Hnub Tim pib siv tau lub khoos kas: Lub Peb Hlis Ntuj Tim 27, 2019